
Will Merck shareholders get Organon stock?
Could you elaborate on the potential implications for Merck shareholders regarding the distribution of Organon stock? Specifically, are there any plans to issue Organon shares directly to Merck shareholders, and if so, what are the proposed terms and conditions? Furthermore, will Merck shareholders have any voting rights or influence over Organon's business decisions after the potential spin-off? Additionally, what are the potential risks and opportunities for Merck shareholders associated with this transaction?
